Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

381 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Thalidomide analogs as emerging anti-cancer drugs.
Dredge K, Dalgleish AG, Marriott JB. Dredge K, et al. Among authors: dalgleish ag. Anticancer Drugs. 2003 Jun;14(5):331-5. doi: 10.1097/00001813-200306000-00001. Anticancer Drugs. 2003. PMID: 12782937 Review.
Thalidomide-derived immunomodulatory drugs as therapeutic agents.
Galustian C, Labarthe MC, Bartlett JB, Dalgleish AG. Galustian C, et al. Among authors: dalgleish ag. Expert Opin Biol Ther. 2004 Dec;4(12):1963-70. doi: 10.1517/14712598.4.12.1963. Expert Opin Biol Ther. 2004. PMID: 15571458 Review.
Phase I study to determine the safety, tolerability and immunostimulatory activity of thalidomide analogue CC-5013 in patients with metastatic malignant melanoma and other advanced cancers.
Bartlett JB, Michael A, Clarke IA, Dredge K, Nicholson S, Kristeleit H, Polychronis A, Pandha H, Muller GW, Stirling DI, Zeldis J, Dalgleish AG. Bartlett JB, et al. Among authors: dalgleish ag. Br J Cancer. 2004 Mar 8;90(5):955-61. doi: 10.1038/sj.bjc.6601579. Br J Cancer. 2004. PMID: 14997189 Free PMC article. Clinical Trial.
381 results